drugset / Trial / NCT05860699

Cannabidiol as an add-on Treatment During Inpatient Alcohol Cessation : CBD-OH

NCT05860699 ↗

Phase 2 Recruiting 210 enrolled Assistance Publique - Hôpitaux de Paris
RandomizedParallel-groupSingle-blindTreatment

Summary

Randomized clinical trial of 11 days Cannabidiol versus placebo as an adjunctive treatment during inpatient alcohol detoxification to improve abstinence in patients with severe alcohol use disorder.

Timeline

Start
2024-04-08
Primary completion
2026-05-23
Completion
2026-05-23

Drugs

EvaluationDrugModalityDoseRoute
Subject Cannabidiol Other / unclassified 450 mg —
Subject Cannabidiol Other / unclassified 900 mg —

Indications